Ultraviolet Blood Radiation
For decades, both medicine and industry have recognized and used ultraviolet light (UV) to kill pathogens. Niels Ryberg Finsen, a Danish physician and scientist, gained a Nobel Prize in Medicine and Physiology in 1903, for pioneering UV therapy with his phototherapy treatment of lupus vulgaris (tuberculosis of the skin, a bacterial infection not related to SLE). His treatment had a 98% success rate. Emmett Knott, a physicist, built on Finsen's work by developing an effective means of using UV radiation to combat internal infections. He withdrew about 1.5 ccs of blood per pound of body weight from a vein, citrated the blood to prevent coagulation, then exposed it to UV radiation by running it through a small radiation chamber before re-injecting the blood back into the vein. The "Knott technique" gained interest from other physicians when Knott and collaborating obstetrician Dr. Virgil K. Hancock published a 1934 article about their experiences with UV therapy. During the 1940s, several American hospitals accepted UV blood irradiation as a highly effective and very safe way to treat infections, including pneumonia (bacterial and viral), septicemia, hepatitis, and acute polio. Interest died out with the arrival of antibiotics.
Ultraviolet blood irradiation (UVBI) does more than inhibit bacteria and viruses. Its documented effects, according to Robert Jay Rowen, MD, include an increase in the blood's oxygen-combining power, activation of steroids, increased cell permeability, activation of sterols into vitamin D, increase in red blood cells, and white cell count normalization. UV apparently also has "a remarkable effect on the autonomic nervous system," according to a report by E. W. Rebbeck who used the therapy in the 1940s to relieve post-surgical paralytic ileus (decrease/absence of intestinal movement). More recently, German researchers have investigated the use of UV blood irradiation for vascular problems, such as peripheral arterial disease and Raynaud's disease. They report an increase in painless walking, improved claudication distances, and decreases in plasma viscosity. Autoimmune disorders, including scleroderma and rheumatoid arthritis, have responded to UV blood irradiation too, according to Dr. Jonathan V. Wright.
Ultraviolet radiation is also a cancer therapy. The US Food and Drug Administration approved ultraviolet treatment, used along with 8-methoxypsoralen (a photosensitizing agent), to treat cutaneous T-cell lymphoma. Dr. Robert Olney used ultraviolet blood irradiation, in conjunction with detoxification techniques, dietary changes, nutritional supplements, and the Koch catalyst to treat a variety of cancers. His pamphlet Blocked Oxidation, privately printed in 1967, recounts cancer reversal in patients with generalized malignant melanoma, highly metastatic colon cancer, thyroid cancer, uterine cancer, and breast cancer penetrating the chest wall and lung.
A Russian study assessing complications in 2380 sessions of UVBI therapy reported that 1.3% of the sessions had "complications associated with the technical performance of the manipulation." Twelve patients also reacted to the ultraviolet blood irradiation itself: "rigor in 4 cases, hypotension in 2 cases, nasal bleeding in 3 cases, hypoglycemia in 1 patient, bronchospasm in 1 patient and urticaria in 1 patient." Eating carbohydrates for an hour or two after the session helps prevent complications.
Townsend Letter November 2008
Rowen RJ. Ultraviolet blood irradiation therapy (photo-oxidation) the cure that time forgot. Int /. Biosocial Med Research. 1996;14(2):115-132. Available at: www. doctorrowen.com/docs/ubi.pdf. Accessed August 7, 2008.
Wright JV. Harnessing the healing power of light Part 2: Time-tested strategies for beating superbugs and more of today's deadliest health threats. Dr. Jonathan V. Wright's Nutrition & Healing. June 2008:15(4): 1-5.
Back to Top